XML 28 R18.htm IDEA: XBRL DOCUMENT v3.23.1
Summary of Significant Accounting Policies (Tables)
3 Months Ended
Mar. 31, 2023
Accounting Policies [Abstract]  
Schedule of Fair Value Measurements
(in thousands)  (Level 1)   (Level 2)   (Level 3)   Total 
   Fair Value Measurements at March 31, 2023 
   Quoted Prices in Active Markets for Identical Assets   Other Observable Inputs   Significant Unobservable Inputs     
(in thousands)  (Level 1)   (Level 2)   (Level 3)   Total 
Derivative liability  $-   $-   $5,890   $5,890 
Total  $-   $-   $5,890   $5,890 
Schedule of Roll Forward of Level 3 Financial Instruments

A roll forward of the level 3 valuation financial instruments is as follows:

 

(In thousands)  Warrants   Notes   Total 
  

Three Months Ended

March 31, 2023

 
(In thousands)  Warrants   Notes   Total 
Balance at December 31, 2022  $5,075   $1,311   $6,386 
Initial valuation of derivative liabilities included in debt discount   265    -    265 
Initial valuation of derivative liabilities included in derivative expense   422    -    422 
Reclassification of derivative liabilities to gain on debt extinguishment   -    (44)   (44)
Change in fair value included in derivative expense (income)   (970)   (169)   (1,139)
Balance at December 31, 2022  $4,792   $1,098   $5,890 
Schedule of Earnings Per Share, Basic and Diluted

The following table presents the computation of net loss per share (in thousands, except share and per share data):

 

(in thousands except share and per share data)  2023   2022 
   March 31, 
(in thousands except share and per share data)  2023   2022 
Numerator          
Net loss  $(886)  $(74)
Preferred stock dividends   (26)   (364)
Net Loss allocable to common stockholders  $(912)  $(438)
Denominator          
Weighted average common shares outstanding used to compute net loss per share, basic and diluted   3,176,952    858,959 
Net loss per share of common stock, basic and diluted          
Net loss per share, basic and diluted  $(0.29)  $(0.51)
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share

The following number of shares have been excluded from diluted net (loss) since such inclusion would be anti-dilutive:

 

   2023   2022 
   March 31, 
   2023   2022 
Stock options outstanding   19,000    19,000 
Convertible notes   5,645,582    2,695,061 
Warrants   9,370,490    3,965,804 
Series C Preferred Stock   3,334    3,334 
Series D Preferred Stock   2,500    2,500 
Series E Preferred Stock   185,980    2,194,844 
Series F Preferred Stock   -    231,360 
Total   15,226,886    9,111,903